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Background:  Left atrial appendage thrombus (LAAT) is the most frequent source of embolic stroke in patients with nonvalvular atrial fibrillation. 
The CHADS2 score is frequently used to predict stroke risk in the setting of atrial fibrillation. We observed that left ventricular diastolic dysfunction 
was prevalent among patients with increased CHADS2 scores. Diastolic function as measured by the ratio of the mitral-inflow velocity (E) to mitral 
valve annulus velocity (e’) is easily obtained through transthoracic echocardiography. We hypothesize that E/e’ ratio as measured by Doppler 
echocardiography predicts LAAT formation independent of the CHADS2 score.
Methods:  We conducted a retrospective cohort study with 275 consecutive adult patients with nonvalvular atrial fibrillation who underwent both a 
transesophageal echocardiogram (TEE) to exclude LAAT and a TTE. The E/e’ ratio was calculated using TTE. A 2-sided T-test was used to compare the 
mean (E/e’) ratio between LAAT(+) and LAAT(-) subjects. A multivariate logistic regression analysis (MVLRA) was used to demonstrate that observed 
differences are independent of known confounders. An ROC curve analysis identified an E/e’ cutoff value, below which, LAAT was highly unlikely.
Results:  Among 275 subjects, 23 (8.3%) had LAAT by TEE. Baseline characteristics in LAAT(+) and LAAT(-) subjects were similar for CHADS2 score (2.53 
vs. 1.84, p=0.09) and antiplatelet (66.7% vs. 49.5%, P=0.2), but not warfarin use (86.7% vs. 56.1%, p=0.02). The mean E/e’ ratio was higher in LAAT(+) 
than LAAT(-) subjects (15.9 vs. 11.6, p=0.012). MVLRA demonstrated that the E/e’ ratio predicts LAAT formation independent of CHADS2 score individual 
components (OR = 1.3, 1.1 - 1.6, p=0.006) and the use of antiplatelet agents and warfarin (p=0.04). ROC curves show that E/e’ is a better predictor for 
LAAT than CHADS2 (AUC 0.73 vs. 0.63) and that none of the patients with E/e’ ≤ 9 had LAAT regardless of CHADS2 score [LR (-) = 0].
Conclusion: These preliminary data suggest that (E/e’) is a better predictor for LAAT than CHADS2, suggesting that diastolic dysfunction mediates 
LAAT formation in patients with atrial fibrillation. This warrants further study with a randomized control trial.
